Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Prostate Cancer Screening Essential Factor for Men’s Quality of Life

Posted Nov 05 2010 11:54am
Posted on 2010-11-02 06:00:00 in Cancer | Diagnostics | Men's Health |

In 1993, routine prostate cancer screening became widely implemented through the use of a prostate specific antigen (PSA) test that was able to catch and diagnose the disease earlier. The test measures the level of prostate specific antigen, a protein produced by the prostate that can be measured through a simple blood test. Increased levels of PSA may be a sign of prostate cancer.  Chandana Reddy, from Cleveland Clinic (Ohio, USA), and colleagues completed a retrospective study was based on data from 1,721 prostate cancer patients who were treated with either radiation therapy or surgery to remove the prostate gland and surrounding tissue at the Cleveland Clinic between 1986 and 1996. To assess the impact of screening, the patients were divided into two groups according to when they were treated: a prescreening era (1986-1992) or a post-screening era (1993-1996). Patients were also classified as having high-, intermediate- or low-risk disease to determine which groups may have benefitted from prostate cancer screening.  The study shows that within each of the three risk groups, patients treated in the prescreening era were significantly more likely to develop metastatic disease within 10 years of treatment, compared to men in the post-screening era. The researchers urge that: "Our study shows that routine screening not only improves the patient's quality of life by stopping metastatic disease, but it also decreases the burden of care for this advanced disease that must be provided by the health care system.  This demonstrates that the PSA test is extremely valuable in catching the disease earlier and allowing men to live more productive lives after treatment."

Chandana Reddy, et al. "The Impact of Screening for Prostate Cancer on the Development of Metastatic Disease after Treatment," presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), Nov. 1, 2010.


Smiling Boomers
Heavy smoking in midlife is associated with a 156% increased risk of developing Alzheimer's disease and a 172% increased risk of developing vascular dementia.
Elevated levels of a hormone produced in the kidneys, erythropoietin, are linked to increased mortality.
Cases of gum disease, most notably periodontis, may be reduced by moderate dietary intakes of the omega-3 polyunsaturated fatty acids DHA and EPA
People who consume several servings of whole grains daily have less visceral adipose tissue, a type of tissue implicated in cardiovascular disease and diabetes.
Men with prostate cancer who undergo radiation therapy or surgery and take an anticoagulant, may cut their risk of dying of the disease by more than half.
Consuming 3.4 ounces or more of tea or coffee daily may significantly reduce the risk of developing glioiblastoma tumors, a form of aggressive brain cancer.
Men treated for prostate cancer who were diagnosed after the start of routine screening are at significantly reduced risk of the disease spreading
Daily consumption of barley, which contains beta-glucan, may significantly reduce both total and LDL cholesterol concentrations.
Olive oil and its phenolic compounds, oleuropein and cafeic acid, exerts beneficial effects on fat oxidation and cardiac energy metabolism.

  
View Current Anti-Aging Newsletter!
Second Opinion with Dr. Ron Klatz Solutions to improve your life, and your lifespan too.
radio tower Dr. Ronald Klatz, A4M physician founder, interviews the world’s top anti-aging experts in health, longevity, brain fitness, aesthetic beauty, and more. Get the answers to look and feel twenty years younger today.
Tune in to Second Opinion with Dr. Ronald Klatz. »
U.S. Events
congresses
Anti-Aging Events
fellowships
fellowships
International Events
 
Post a comment
Write a comment:

Related Searches